TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action
The DOI matches its Crossref record.
Abstract
In the present report, the induction of the HLA-DRA gene in response to IFN-γ is shown to be selectively attenuated by TGF-beta. Thus, the accumulation in response to IFN-γ of mRNA for the DRA gene, but not for the guanylate binding protein-2 gene, is markedly reduced in the presence of TGF-beta. Moreover, the data presented show that the mechanism by which TGF-beta inhibits expression of DRA involves attenuation of the class II transactivator (CIITA) gene. This conclusion is based on the finding that induction of CIITA gene expression in response to IFN-γ is completely abrogated in TGF-beta-treated cells. In contrast, TGF-beta did not affect IFN-γ-induced tyrosine phosphorylation of Jak1, Jak2, or the signal transducer and activator of transcription-1 (Stat1). TGF-beta also did not inhibit the appearance of IFN-γ-activated, Stat1 DNA-binding activity in intact cells. Thus, the effects of TGF-beta on CIITA could not be explained by altered signaling through Jak-Stat1. Potential alternative targets for the inhibitory effects of TGF-beta were identified in renaturation tyrosine kinase assays, which revealed three IFN-γ-activated protein tyrosine kinases that, in contrast to the Janus kinases, are sensitive to TGF-beta. These findings 1) indicate that inhibition of MHC class II gene expression by TGF-beta involves attenuation of the CIITA gene independently of effects on Janus kinases, 2) provide direct evidence that IFN-γ activates both Janus and non-Janus protein tyrosine kinases, and 3) identify an accessory pathway of IFN-γ action involving tyrosine kinases that, unlike the Jak-Stat1 pathway, are impaired by TGF-beta.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Transforming Growth Factor-β Signaling in Immunity and Cancer
Batlle, E., & Massagué, J. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.024 · Cited by 2,366
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
Transforming growth factor-β in T-cell biology
Gorelik, L., & Flavell, R. A. (2002) · Nature Reviews Immunology · doi:10.1038/nri704 · Cited by 792
Combination strategies to maximize the benefits of cancer immunotherapy
Zhu, S., Zhang, T., Zheng, L., Liu, H., Song, W., Liu, D., Li, Z., & Pan, C.-X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01164-5 · Cited by 654
“In dendritic cells, TGF-β suppresses expression of MHC-II genes and inhibits antigen presentation [164, 165].”
Background
Metadata
- Authors
- Nandan, D., & Reiner, N. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-02-01
- Volume
- 158
- Issue
- 3
- Pages
- 1095-1101
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1750701169
- Cited by
- 129
- References
- 0
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. https://app.cochat.ai/papers/10.4049/jimmunol.158.3.1095
- The paper
- Nandan, D., & Reiner, N. E. (1997). TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. The Journal of Immunology. https://doi.org/10.4049/jimmunol.158.3.1095
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.